Stock STX SHIELD THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shield Therapeutics plc

Equities

STX

GB00BYV81293

Delayed London S.E.
Other stock markets
 05:41:34 2024-05-02 am EDT 		5-day change 1st Jan Change
1.729 GBX -1.20% Intraday chart for Shield Therapeutics plc +21.33% -74.19%
Apr. 30 EARNINGS AND TRADING: Software Circle & Beximco report higher revenue AN
Apr. 30 Transcript : Shield Therapeutics plc, 2023 Earnings Call, Apr 30, 2024

Evolution of the average Target Price on Shield Therapeutics plc

Price target over the last 5 years

History of analyst recommendation changes

3dc456eafa53.661aqaGJjjdeGdXNogdz378IM1ioI-7QbcegsZnlPMM.jZUOnv7N9F81aa28xXc7t-VjASvKebHlVZP54tSGZaDYgDnIzrjFRGxKtg~c1ad4361341a669bec42d5dbfd10d2b4

Analyst Recommendations on Shield Therapeutics plc

FTSE 100 Closes Up 0.1% as Investors Eye Fed, ECB Rate Decisions DJ
UK Wage Growth Will Keep Interest Rates High DJ
FTSE 100 Closes Down 0.3% Amid Increasing Concerns of Fed's Rate Hike DJ
Sterling Unlikely to Fall Materially if BOE Pauses Rate Rise Cycle DJ
Sterling May Fall Vs Euro as BOE Rate Rise Bets Overdone DJ
UK Unemployment Rate Expected to Increase to 5% by End of 2023 DJ
Strong UK Wage Growth Could Prompt Higher-Than-Expected BOE Rate Rise DJ
Sterling Seen Lifted by BOE Rate Rise Bets DJ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0175 GBP
Average target price
0.02 GBP
Spread / Average Target
+14.29%
High Price Target
0.02 GBP
Spread / Highest target
+14.29%
Low Price Target
0.02 GBP
Spread / Lowest Target
+14.29%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shield Therapeutics plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. STX Stock
  4. Consensus Shield Therapeutics plc